First City Capital Management, Inc. Astrazeneca PLC Transaction History

First City Capital Management, Inc.

$175 Million
Q2 2024

A detailed history of First City Capital Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, First City Capital Management, Inc. holds 8,313 shares of AZN stock, worth $593,797. This represents 0.37% of its overall portfolio holdings.

Number of Shares

8,313

Previous 10,186 18.39%

Holding current value

$593,797

Previous $690,000 6.09%

% of portfolio

0.37%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $125,135 - $151,394	-1,873 Reduced 18.39%	8,313 $648,000
Q2 2023 Jul 19, 2023	SELL	$69.91 - $75.81 $99,412 - $107,801	-1,422 Reduced 12.25%	10,186 $729,000
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $63 - $71	-1 Reduced 0.01%	11,608 $805,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $66,895 - $86,922	-1,234 Reduced 9.61%	11,609 $787,000
Q3 2022 Oct 24, 2022	SELL	$53.02 - $135.75 $5,302 - $13,575	-100 Reduced 0.77%	12,843 $704,000
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $54,020 - $63,830	-1,000 Reduced 7.17%	12,943 $721,000
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $15,203 - $18,896	314 Added 2.3%	13,943 $801,000
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $28,767 - $33,208	-610 Reduced 4.28%	13,629 $743,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $880,395 - $1.05 Million	-18,145 Reduced 56.03%	14,239 $713,000
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $759,166 - $874,035	14,305 Added 79.12%	32,384 $1.77 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $39,824 - $51,106	924 Added 5.39%	18,079 $956,000
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $9,553 - $11,353	225 Added 1.33%	17,155 $855,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $68,204 - $77,299	-1,700 Reduced 9.13%	16,930 $755,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $11,058 - $12,447	-300 Reduced 1.58%	18,630 $708,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $17,380 - $19,860	-500 Reduced 2.57%	18,930 $749,000
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $6,909 - $7,409	200 Added 1.04%	19,430 $682,000
Q3 2017 Oct 31, 2017	BUY	$28.96 - $34.0 $8,688 - $10,200	300 Added 1.58%	19,230 $652,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,930	18,930 $645,000

Others Institutions Holding AZN

# of Institutions

1,348

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Astrazeneca PLC Transaction History